Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Opening and Negative Controlled Clinical Study of Autologous Multiple Targets DC-CTL Combined With CIK for Advanced Solid Tumor

NCT03047525 is registered in ClinicalTrials.gov with Xiaoyi Huang as lead sponsor.

NCT NCT03047525
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03047525 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Opening and Negative Controlled Clinical Study of Autologous Multiple Targets DC-CTL Combined With CIK for Advanced Solid Tumor
Lead sponsor
Xiaoyi Huang
Phase
Phase 1/2
Overall status
Unknown status
Start date
February 20, 2017
Completion date
December 1, 2020
Enrollment
200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

colorectal cancer, lung cancer, nasopharyngeal carcinoma, renal cell carcinoma